News
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million
Catalent, Inc , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products,...
Clinical Trials
Elsevier creates free information center to bring together latest clinical research on novel coronavirus 2019-nCoV
For the benefit of healthcare professionals, medical researchers and the public, Elsevier, a global information analytics business specializing in science and health, has created...
Clinical Trials
Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services
Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner,...
IT & Data Management
Accenture and Google Cloud Collaborate to Help Life Sciences Companies Advance the Discovery, Development and Delivery of Innovative Therapies
Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accentureโs INTIENT life sciences industry platform.
The new, multi-year agreement...
Press Releases
RauCon Pharma Partnering Conferences Limit Attendance For More Value
RauCon has now introduced limits to the number of participants of its euroPLX and asiaPLX Pharma Partnering Conferences in order to increase their value...
Clinical Trials
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its...
IT & Data Management
Clinerion and Datametrix partner to deliver RWE insights from Real World Data from Clinerion’s global hospital network
The partners will deliver an integrated clinical research offer transforming Real World Data (RWD) from the global site and patient network on Clinerionโs Patient...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















